Backbone-Determined Antiarrhythmic Structure-Activity Relationships for a Mirror Image, Oligomeric Depsipeptide Natural Product.
Madelaine P ThorpeDaniel J BlackwellBjorn C KnollmannJeffrey N JohnstonPublished in: Journal of medicinal chemistry (2024)
Cyclic oligomeric depsipeptides (COD) are a structural class within naturally occurring compounds with a wide range of biological activity. Verticilide is a COD (24-membered ring) that was identified by its inhibition of insect ryanodine receptor (RyR). We have since found that the enantiomer of verticilide ( ent -verticilide, 1 ) is a potent inhibitor of mammalian RyR2, a cardiac calcium channel, and therefore a potential antiarrhythmic agent. Oddly, nat -verticilide does not inhibit RyR2. To further develop ent -verticilide as an antiarrhythmic, we explored potential SAR through systematic modification of the ester's functionality to both N -H and N -Me amides. The syntheses of these ent -verticilide-inspired analogs are detailed using a monomer-based platform enabled by enantioselective catalysis. Two analogs among 23 exhibited measurable reduction of calcium sparks in a functional assay of RyR2 activity. These findings illustrate the value of natural product-inspired therapeutic development, but the less-studied approach where the non-natural enantiomeric series harbors important SAR.